Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients.
Nucci
M
M
Nouér
S A
SA
Garnica
M
M
de Oliveira
A L M
AL
Maiolino
A
A
D001424:Bacterial Infections / Q000453:epidemiology / Q000517:prevention & control*; D015331:Cohort Studies; D004351:Drug Resistance; D005334:Fever / Q000453:epidemiology / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D000077731:Meropenem; D015999:Multivariate Analysis; D009503:Neutropenia / Q000188:drug therapy*; D016017:Odds Ratio; D012107:Research Design; D012307:Risk Factors; D013845:Thienamycins / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D013845:Thienamycins; D000077731:Meropenem